| Affiliation: | 1. Global Pharma Development Strategy, Novartis Pharmaceuticals, Switzerland;2. Head of Toxicology, Genentech, United States;3. Discovery Toxicology, Bristol-Myers Squibb, United States;4. Preclinical Safety, Novartis Institutes for Biomedical Research, Switzerland;5. Safety Pharmacology COE, Pfizer, United States;6. Preclinical Safety, Novartis Institutes for Biomedical Research, Switzerland;7. Preclinical Safety Profiling, Novartis Institutes for Biomedical Research, United States;1. Department of Chemistry, Laboratory of Medicinal Chemistry and Neuroengineering, Medical University of Lublin, Chodzki 4a Street, 20-093 Lublin, Poland;2. Department of Medical Education, California Northstate University College of Medicine, 9700 West Taron Drive, Elk Grove, CA 95757, USA;1. Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, James Buchanan Brady Urological Institute and Department of Urology, Johns Hopkins School of Medicine and Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland;2. Division of Cancer Prevention, National Cancer Institute, National Institutes of Health, Department of Health and Human Services, Bethesda, Maryland;3. Medical Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Department of Health and Human Services, Bethesda, Maryland;4. Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Department of Health and Human Services, Bethesda, Maryland;5. SWOG Statistical Center, Fred Hutchinson Cancer Research Center, Seattle, Washington;6. Cancer Prevention Program, Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, Washington;7. Center for Clinical and Translational Research, Cleveland Clinic Lerner College of Medicine, Cleveland, Ohio;8. University of Colorado Denver School of Medicine, Aurora, Colorado;9. Department of Urology, University of Texas Health Sciences Center San Antonio, San Antonio, Texas;1. Division of Internal Medicine, Mayo Clinic, Rochester, Minnesota;2. Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota;1. Facility for Risk Assessment and Intervention Studies, Department of Pharmacology and Toxicology, National Institute of Pharmaceutical Education and Research, Sector 67, S.A.S. Nagar, Punjab 160062, India;2. Laboratory of Epigenetics and Diseases, Department of Pharmacology and Toxicology, National Institute of Pharmaceutical Education and Research, Sector 67, S.A.S. Nagar, Punjab 160062, India;3. Icon Analytical Equipment Pvt Ltd, 501, Pragati Deep Building, 5th Floor, Plot No. 8, Laxmi Nagar, District Centre, Vikas Marg, Delhi 110092, India |
